首页> 外文期刊>Yonsei Medical Journal >A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments
【24h】

A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments

机译:短和简单的表面活性剂蛋白B和C类似物的组合作为一种新的合成表面活性剂:体外和动物实验。

获取原文
           

摘要

Purpose Pulmonary surfactants for preterm infants contain mostly animal-derived surfactant proteins (SPs), which are essential for lowering surface tension. We prepared artificial pulmonary surfactants using synthetic human SP analogs and performed in vitro and in vivo experiments. Materials and Methods We synthesized peptide analogues that resemble human SP-B (RMLPQLVCRLVLRCSMD) and SP-C (CPVHLKRLLLLLLLLLLLLLLLL). Dipalmitoylphosphatidylcholine (DPPC), phosphatidylglycerol (PG), and palmitic acid (PA) were added and mixed in lyophilized to render powdered surfactant. Synsurf-1 was composed of DPPC:PG:PA:SP-B (75:25:10:3, w/w); Synsurf-2 was composed of DPPC:PG:PA:SP-C (75:25:10:3, w/w); and Synsurf-3 was composed of DPPC:PG:PA:SP-B:SP-C (75:25:10:3:3, w/w). We performed in vitro study to compare the physical characteristics using pulsating bubble surfactometer and modified Wilhelmy balance test. Surface spreading and adsorption test of the surfactant preparations were measured. In vivo test was performed using term and preterm rabbit pups. Pressure-volume curves were generated during the deflation phase. Histologic findings were examined. Results Pulsating bubble surfactometer readings revealed following minimum and maximum surface tension (mN/m) at 5 minutes: Surfacten? (5.5±0.4, 32.8±1.6), Synsurf-1 (16.7±0.6, 28.7±1.5), Synsurf-2 (7.9±1.0, 33.1±1.6), and Synsurf-3 (7.1±0.8, 34.5±1.0). Surface spreading rates were as follows: Surfacten? (27 mN/m), Synsurf-1 (43 mN/m), Synsurf-2 (27 mN/m), and Synsurf-3 (27 mN/m). Surface adsorption rate results were as follows: Surfacten? (28 mN/m), Synsurf-1 (35 mN/m), Synsurf-2 (29 mN/m), and Synsurf-3 (27 mN/m). The deflation curves were best for Synsurf-3; those for Synsurf-2 were better than those for Surfacten?. Synsurf-1 was the worst surfactant preparation. Microscopic examination showed the largest aerated area of the alveoli in the Synsurf-3 group, followed by Synsurf-1 and Surfacten?; Synsurf-2 was the smallest. Conclusion Synsurf-3 containing both SP-B and SP-C synthetic analogs showed comparable and better efficacy than commercially used Surfacten? in lowering surface tension, pressure-volume curves, and tissue aerated area of the alveoli.
机译:目的早产儿肺表面活性剂主要包含动物衍生的表面活性剂蛋白(SPs),这对于降低表面张力至关重要。我们使用合成人SP类似物制备了人工肺表面活性剂,并进行了体外和体内实验。材料和方法我们合成了类似于人SP-B(RMLPQLVCRLVLRCSMD)和SP-C(CPVHLKRLLLLLLLLLLLLLLLLLL)的肽类似物。加入二棕榈酰磷脂酰胆碱(DPPC),磷脂酰甘油(PG)和棕榈酸(PA),并冻干混合以得到粉末状表面活性剂。 Synsurf-1由DPPC:PG:PA:SP-B(75:25:10:3​​,w / w)组成; Synsurf-2由DPPC:PG:PA:SP-C(75:25:10:3​​,w / w)组成; Synsurf-3由DPPC:PG:PA:SP-B:SP-C(75:25:10:3​​:3,w / w)组成。我们进行了体外研究,以比较使用脉动气泡表面张力计和改进的Wilhelmy平衡测试的物理特性。测量表面活性剂制剂的表面铺展和吸附试验。使用足月和早产兔幼崽进行体内测试。在放气阶段生成压力-体积曲线。检查组织学结果。结果脉动气泡表面张力计读数显示5分钟后的最小和最大表面张力(mN / m):表面活性剂? (5.5±0.4、32.8±1.6),Synsurf-1(16.7±0.6、28.7±1.5),Synsurf-2(7.9±1.0、33.1±1.6)和Synsurf-3(7.1±0.8、34.5±1.0)。表面扩散率如下:表面活性剂? (27 mN / m),Synsurf-1(43 mN / m),Synsurf-2(27 mN / m)和Synsurf-3(27 mN / m)。表面吸附率的结果如下:表面活性剂? (28 mN / m),Synsurf-1(35 mN / m),Synsurf-2(29 mN / m)和Synsurf-3(27 mN / m)。通缩曲线最适合Synsurf-3; Synsurf-2的性能优于Surfacten? Synsurf-1是最差的表面活性剂制剂。显微镜检查显示,Synsurf-3组的肺泡充气面积最大,其次是Synsurf-1和Surfacten?。 Synsurf-2最小。结论含有SP-B和SP-C合成类似物的Synsurf-3与市售Surfacten?相比具有可比的更好的疗效。降低表面张力,压力-容量曲线和肺泡的组织充气区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号